Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial Fibrillation

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.

Also called NCT02008448

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02008448
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Russia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02008448. Randomized; double masking; primary purpose treatment. Start 2013-06 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial Fibrillation
Condition
Persistent Atrial Fibrillation
Intervention (Procedure)
Pulmonary vein isolation
Intervention (Procedure)
Linear Lesion Ablation
Intervention (Drug)
BT injection
Lead sponsor
Meshalkin Research Institute of Pathology of Circulation (class: research network)

Record details

Record id
cardio:ct-nct02008448
Content hash
f5dc015c1bdf5cc864ba2feafbf49394bbc7050383b490f505a3366717f0e92c